Cooper Total Long Term Liabilities 2010-2025 | COO
Cooper total long term liabilities from 2010 to 2025. Total long term liabilities can be defined as the sum of all non-current liabilities.
- Cooper total long term liabilities for the quarter ending January 31, 2025 were $3.095B, a 8.22% decline year-over-year.
- Cooper total long term liabilities for 2024 were $3.209B, a 2.23% increase from 2023.
- Cooper total long term liabilities for 2023 were $3.139B, a 3.34% increase from 2022.
- Cooper total long term liabilities for 2022 were $3.037B, a 57.21% increase from 2021.
Cooper Annual Total Long Term Liabilities
(Millions of US $) |
| 2024 |
$3,209 |
| 2023 |
$3,139 |
| 2022 |
$3,037 |
| 2021 |
$1,932 |
| 2020 |
$1,908 |
| 2019 |
$1,535 |
| 2018 |
$2,269 |
| 2017 |
$1,287 |
| 2016 |
$1,240 |
| 2015 |
$1,217 |
| 2014 |
$1,428 |
| 2013 |
$393 |
| 2012 |
$466 |
| 2011 |
$420 |
| 2010 |
$659 |
| 2009 |
$836 |
Cooper Quarterly Total Long Term Liabilities
(Millions of US $) |
| 2025-01-31 |
$3,095 |
| 2024-10-31 |
$3,209 |
| 2024-07-31 |
$3,213 |
| 2024-04-30 |
$3,291 |
| 2024-01-31 |
$3,372 |
| 2023-10-31 |
$3,139 |
| 2023-07-31 |
$3,175 |
| 2023-04-30 |
$3,212 |
| 2023-01-31 |
$3,310 |
| 2022-10-31 |
$3,037 |
| 2022-07-31 |
$3,093 |
| 2022-04-30 |
$3,116 |
| 2022-01-31 |
$3,072 |
| 2021-10-31 |
$1,932 |
| 2021-07-31 |
$1,762 |
| 2021-04-30 |
$1,858 |
| 2021-01-31 |
$1,971 |
| 2020-10-31 |
$1,908 |
| 2020-07-31 |
$1,859 |
| 2020-04-30 |
$1,857 |
| 2020-01-31 |
$1,749 |
| 2019-10-31 |
$1,535 |
| 2019-07-31 |
$1,668 |
| 2019-04-30 |
$1,720 |
| 2019-01-31 |
$1,935 |
| 2018-10-31 |
$2,269 |
| 2018-07-31 |
$2,569 |
| 2018-04-30 |
$2,766 |
| 2018-01-31 |
$2,697 |
| 2017-10-31 |
$1,287 |
| 2017-07-31 |
$1,318 |
| 2017-04-30 |
$1,467 |
| 2017-01-31 |
$1,319 |
| 2016-10-31 |
$1,240 |
| 2016-07-31 |
$1,535 |
| 2016-04-30 |
$1,534 |
| 2016-01-31 |
$1,447 |
| 2015-10-31 |
$1,217 |
| 2015-07-31 |
$1,199 |
| 2015-04-30 |
$1,241 |
| 2015-01-31 |
$1,436 |
| 2014-10-31 |
$1,428 |
| 2014-07-31 |
$393 |
| 2014-04-30 |
$395 |
| 2014-01-31 |
$393 |
| 2013-10-31 |
$393 |
| 2013-07-31 |
$320 |
| 2013-04-30 |
$401 |
| 2013-01-31 |
$494 |
| 2012-10-31 |
$466 |
| 2012-07-31 |
$555 |
| 2012-04-30 |
$362 |
| 2012-01-31 |
$456 |
| 2011-10-31 |
$420 |
| 2011-07-31 |
$490 |
| 2011-04-30 |
$609 |
| 2011-01-31 |
$664 |
| 2010-10-31 |
$659 |
| 2010-07-31 |
$685 |
| 2010-04-30 |
$758 |
| 2010-01-31 |
$791 |
| 2009-10-31 |
$836 |
| 2009-07-31 |
$855 |
| 2009-04-30 |
$906 |
| 2009-01-31 |
$918 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$15.859B |
$3.895B |
|
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
|
